Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With or Without AS03 (COVID-19)
Clinical trial NCT04750343 · UNKNOWN
Trial details
- NCT number
- NCT04750343
- Sponsor
- SK Bioscience Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-03
- Primary completion
- 2021-07-28
- Enrollment
- 328
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.